Non-coding RNAs in Human Health and Disease: Potential Function As Biomarkers and Therapeutic Targets
Overview
Molecular Biology
Affiliations
Human diseases have been a critical threat from the beginning of human history. Knowing the origin, course of action and treatment of any disease state is essential. A microscopic approach to the molecular field is a more coherent and accurate way to explore the mechanism, progression, and therapy with the introduction and evolution of technology than a macroscopic approach. Non-coding RNAs (ncRNAs) play increasingly important roles in detecting, developing, and treating all abnormalities related to physiology, pathology, genetics, epigenetics, cancer, and developmental diseases. Noncoding RNAs are becoming increasingly crucial as powerful, multipurpose regulators of all biological processes. Parallel to this, a rising amount of scientific information has revealed links between abnormal noncoding RNA expression and human disorders. Numerous non-coding transcripts with unknown functions have been found in addition to advancements in RNA-sequencing methods. Non-coding linear RNAs come in a variety of forms, including circular RNAs with a continuous closed loop (circRNA), long non-coding RNAs (lncRNA), and microRNAs (miRNA). This comprises specific information on their biogenesis, mode of action, physiological function, and significance concerning disease (such as cancer or cardiovascular diseases and others). This study review focuses on non-coding RNA as specific biomarkers and novel therapeutic targets.
Liu Q, Sun Z, Liu Y, He X, Ren C, Wang X BMC Genomics. 2025; 26(1):250.
PMID: 40087554 DOI: 10.1186/s12864-025-11438-8.
Emerging Roles of Long Non-Coding RNAs in Cardiovascular Diseases.
Kong X, Li F, Wang Y J Cell Mol Med. 2025; 29(5):e70453.
PMID: 40032652 PMC: 11875779. DOI: 10.1111/jcmm.70453.
Khan S, Tao F Biomedicines. 2025; 13(2).
PMID: 40002847 PMC: 11853523. DOI: 10.3390/biomedicines13020434.
Non-Coding RNAs in Cancer: Structure, Function, and Clinical Application.
Marton E, Varga A, Domoszlai D, Buglyo G, Balazs A, Penyige A Cancers (Basel). 2025; 17(4).
PMID: 40002172 PMC: 11853212. DOI: 10.3390/cancers17040579.
Guo X, Li S Oncol Rep. 2025; 53(4).
PMID: 39981932 PMC: 11865881. DOI: 10.3892/or.2025.8879.